Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
8.77
-0.45 (-4.88%)
At close: Sep 25, 2026, 4:00 PM EDT
8.82
+0.05 (0.57%)
After-hours: Sep 25, 2026, 7:58 PM EDT
Q32 Bio Stock Forecast
Stock Price Forecast
According to 5 analysts polled by S&P Global, Q32 Bio stock has a consensus rating of "Strong Buy" and an average price target of $42.25. The average 1-year stock price forecast is 381.76% higher than the current stock price, while the lowest is $34 (+287.69%) and the highest is $59 (+572.75%).
Price Target: $42.25 (+381.76%)
Analyst Consensus: Strong Buy
Price Target
Chart* Price targets were last updated on Aug 24, 2026.
Analyst Ratings
The average analyst rating for Q32 Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 4 | 5 | 5 | 4 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 1 | 1 | 1 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 5 | 5 | 6 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Buy Initiates $34 | Buy | Initiates | $34 | +287.69% | Aug 24, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $40 | Buy | Maintains | $40 | +356.10% | Aug 6, 2026 |
| Wells Fargo | Wells Fargo | Buy Reiterates $66 → $59 | Buy | Reiterates | $66 → $59 | +572.75% | Aug 6, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $36 | Buy | Reiterates | $36 | +310.49% | Aug 5, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $14 → $36 | Buy | Reiterates | $14 → $36 | +310.49% | Jul 13, 2026 |
Financial Forecast
Revenue This Year
500.00K
from 53.74M
Decreased by -99.07%
Revenue Next Year
1.25M
from 500.00K
Increased by 150.00%
EPS This Year
-1.13
EPS Next Year
-1.02
from -1.13
EPS and Forward PE are based on non-GAAP adjusted numbers.